<?xml version="1.0" encoding="UTF-8"?>
<ref id="B39-vaccines-07-00199">
 <label>39.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vermeire</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Barbezange</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Francart</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hamouda</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Litzroth</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Hutse</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Martens</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Vandermarliere</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Van Gucht</surname>
    <given-names>S.</given-names>
   </name>
  </person-group>
  <article-title>Sera from different age cohorts in Belgium show limited cross-neutralisation between the mumps vaccine and outbreak strains</article-title>
  <source>Clin. Microbiol. Infect.</source>
  <year>2019</year>
  <volume>25</volume>
  <pub-id pub-id-type="doi">10.1016/j.cmi.2018.11.016</pub-id>
  <?supplied-pmid 30502489?>
  <pub-id pub-id-type="pmid">30502489</pub-id>
 </element-citation>
</ref>
